Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions

Toxicology

Volumn 275, Issue 1-3, 2010, Pages 10-20

  Stinn, Walter ^a   Arts, Josje H E ^b,d   Buettner, Ansgar ^a   Duistermaat, Evert ^b   Janssens, Kris ^a   Kuper, C Frieke ^b   Haussmann, Hans Juergen ^c  

^a Philip Morris Research Laboratories GmbH   (Germany)

^b TNO   (Netherlands)

^c Toxicology Consultant ^*  (Germany)

^d AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

Author keywords

Cigarette mainstream smoke; Gas vapor phase; Lung tumorigenesis; Particulate phase; Pulmonary inflammation

Indexed keywords

CELL MARKER; MOLECULAR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPITHELIUM HYPERPLASIA; GAS; GENETIC SUSCEPTIBILITY; INFLAMMATION; LARYNX DISORDER; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG LAVAGE; LUNG METASTASIS; MALE; METAPLASIA; MOUSE; NONHUMAN; NOSE DISEASE; PARTICULATE MATTER; PRIORITY JOURNAL; VAPOR;

ANIMALS; GASES; INHALATION EXPOSURE; LUNG NEOPLASMS; MALE; MICE; PARTICULATE MATTER; SMOKING; TOBACCO SMOKE POLLUTION; VOLATILIZATION;

ANIMALIA; MURINAE; MUS; NICOTIANA TABACUM;

EID: 77954816222     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.05.005     Document Type: Article

References (69)

1. Association for the Assessment and Accreditation of Laboratory Animal Care International American Association for Laboratory Animal Science Policy on the Humane Care and Use of Laboratory Animals. Lab. Anim. Sci. 1991, 41:91.
2. Baker R.R. Smoke chemistry: chapter 12. Tobacco: Production, Chemistry and Technology 1999, 398-439. Blackwell Science, Oxford, UK. D.L. Davis, M.T. Nielsen (Eds.).
3. Bauer A., Rondini E. The role of inflammation in mouse pulmonary neoplasia. Vet. Pathol. 2009, 46:369-390.
4. Bauer C. On the respiratory function of haemoglobin. Rev. Physiol. Biochem. Pharmacol. 1974, 70:1-31.
5. Brambilla C., Fievet F., Jeanmart M., de Fraipont F., Lantuejoul S., Frappat V., Ferretti G., Brichon P.Y., Moro-Sibilot D. Early detection of lung cancer: role of biomarkers. Eur. Respir. J. Suppl. 2003, 39:36s-44s.
6. Chen P.X., Moldoveanu S.C. Mainstream smoke chemical analyses for 2R4F Kentucky reference cigarette. Beitr. Tabakforsch. Int. 2003, 20:448-458.
7. Coggins C.R.E., Fouillet X.L.M., Lam R., Morgan K.T. Cigarette smoke induced pathology of the rat respiratory tract: a comparison of the effects of the particulate and vapour phases. Toxicology 1980, 16:83-101.
8. Coggins C.R.E. An updated review of inhalation studies with cigarette smoke in laboratory animals. Int. J. Toxicol. 2007, 26:331-338.
9. Curtin G.M., Higuchi M.A., Ayres P.H., Swauger J.E., Mosberg A.T. Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation. Toxicol. Sci. 2004, 81:26-34.
10. Curtin G.M., Potts R.J., Ayres P.H., Doolittle D.J., Swauger J.E. Adaptation to toxicant exposure during rodent lung tumorigenesis. Toxicology of the Lung 2006, 587-622. CRC Press (Taylor Francis), Boca Raton, FL. D.E. Gardner (Ed.).
11. D'Agostini F., Balansky R.M., Bennicelli C., Lubet R.A., Kelloff G.J., De Flora S. Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int. J. Oncol. 2001, 18:607-615.
12. De Flora S., D'Agostini F., Balansky R., Camoirano A., Bennicelli C., Bagnasco M., Cartiglia C., Tampa E., Longobardi M.G., Lubet R.A., Izzotti A. Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutat. Res. 2003, 523-524:237-252.
13. Devesa S.S., Bray F., Vizcaino A.P., Parkin D.M. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer 2005, 117:294-299.
14. Dungworth D.L., Rittinghausen S., Schwartz L., Harkema J.R., Hayashi Y., Kittel B., Lewis D., Miller R.A., Mohr U., Rehm S., Slayter M.V. Respiratory system and mesothelium. International Classification of Rodent Tumors, The Mouse 2001, 87-139. Springer, Berlin, Germany. U. Mohr (Ed.).
15. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1955, 50:1096-1121.
16. Engels E.A. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev. Anticancer Ther. 2008, 8:605-615.
17. Essenberg J.M. Cigarette smoke and the incidence of primary neoplasm of the lung in the albino mouse. Science 1952, 116:561-562.
18. Essenberg J.M. Further study of tumor formation in the lungs of the albino mice. West. J. Surg. Obstet. Gynecol. 1957, 65:161-163.
19. Finch G.L., Nikula K.J., Belinsky S.A., Barr E.B., Stoner G.D., Lechner J.F. Failure of cigarette smoke to induce or promote lung cancer in the A/J mouse. Cancer Lett. 1996, 99:161-167.
20. Fisher G.H., Wellen S.L., Klimstra D., Lenczowski J.M., Tichelaar J.W., Lizak M.J., Whitsett J.A., Koretsky A., Varmus H.E. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 2001, 15:3249-3262.
21. Friedrichs B., Miert E., Vanscheeuwijck P. Lung inflammation in rats following subchronic exposure to cigarette mainstream smoke. Exp. Lung Res. 2006, 32:151-179.
22. Gazdar A.F., Shigematsu H., Herz J., Minna J.D. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?. Trends Mol. Med. 2004, 10:481-486.
23. Gordon T., Bosland M. Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke. Cancer Lett. 2009, 275:213-220.
24. Hamm J.T., Yee S., Rajendran N., Morrissey R.L., Richter S.J., Misra M. Histological alterations in male A/J mice following nose-only exposure to tobacco smoke. Inhal. Toxicol. 2007, 19:405-418.
25. Hatsukami D.K., Giovino G.A., Eissenberg T., Clark P.I., Lawrence D., Leischow S. Methods to assess potential reduced exposure products. Nicotine Tob. Res. 2005, 7:827-844.
26. Haussmann H.-J., Anskeit E., Becker D., Kuhl P., Stinn W., Teredesai A., Voncken P., Walk R.A. Comparison of fresh and room-aged cigarette sidestream smoke in a subchronic inhalation study on rats. Toxicol. Sci. 1998, 41:100-116.
27. Haussmann H.-J. Smoking and lung cancer: future research directions. Int. J. Toxicol. 2007, 26:353-364.
28. Hodge-Bell K.C., Lee K.M., Renne R.A., Gideon K.M., Harbo S.J., McKinney W.J. Pulmonary inflammation in mice exposed to mainstream cigarette smoke. Inhal. Toxicol. 2007, 19:361-376.
29. Hooftman R.N., Kuper C.F., Appelman L.M. Comparative sensitivity of histo-pathology and specific lung parameters in the detection of lung injury. J. Appl. Toxicol. 1988, 8:59-65.
30. Hutt J.A., Vuillemenot B.R., Barr E.B., Grimes M.J., Hahn F.F., Hobbs C.H., March T.H., Gigliotti A.P., Seilkop S.K., Finch G.L., Mauderly J.L., Belinsky S.A. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis 2005, 26:1999-2009.
31. International Agency for Research on Cancer, 2004. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon, France.
32. International Organization for Standardization International Standard 3402: Tobacco and Tobacco Products-Atmosphere for Conditioning and Testing 1991, International Organization for Standardization, Geneva, Switzerland.
33. International Organization for Standardization International Standard 3308: Routine Analytical Cigarette-Smoking Machine-Definitions and Standard Conditions 2000, International Organization for Standardization, Geneva, Switzerland.
34. Kim C.F.B., Jackson E.L., Kirsch D.G., Grimm J., Shaw A.T., Lane K., Kissil J., Olive K.P., Sweet-Cordero A., Weissleder R., Jacks T. Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:241-250.
35. Klus H., Kuhn H. Distribution of various tobacco smoke components among mainstream and sidestream smoke (a survey). Beitr. Tabakforsch. Int. 1982, 11:229-265.
36. Leuchtenberger C., Leuchtenberger R., Zbinden I. Gas vapour phase constituents and SH reactivity of cigarette smoke influence lung cultures. Nature 1974, 247(442):565-567.
37. Liu P., Wang Y., Vikis H., Maciag A., Wang D., Lu Y., Liu Y., You M. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat. Genet. 2006, 38:888-895.
38. Lofdahl J.M., Wahlstrom J., Skold C.M. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 2006, 145:428-437.
39. Malkinson A.M. The genetic basis of susceptibility to lung tumors in mice. Toxicology 1989, 54:241-271.
40. Malkinson A.M. Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 2001, 32:265-279.
41. Manenti G., Dragani T.A. Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis. Carcinogenesis 2005, 26:875-882.
42. Maria D.A., Manenti G., Galbiati F., Ribeiro O.G., Cabrera W.H., Barrera R.G., Pettinicchio A., De F.M., Starobinas N., Siqueira M., Dragani T.A., Ibanez O.M. Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Oncogene 2003, 22:426-432.
43. Mauderly J.L., Gigliotti A.P., Barr E.B., Bechtold W.E., Belinsky S.A., Hahn F.F., Hobbs C.A., March T.H., Seilkop S.K., Finch G.L. Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicol. Sci. 2004, 81:280-292.
44. Melnick R.L., Shackelford C.C., Huff J. Carcinogenicity of 1,3-butadiene. Environ. Health Perspect. 1993, 100:227-236.
45. Morgan G.D., Backinger C.L., Leischow S.J. The future of tobacco-control research. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1077-1080.
46. Muller T., Gebel S. The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration. Carcinogenesis 1998, 19:797-801.
47. Organization for Economic Co-operation and Development Environment Directorate The OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring-Number 1 1998, Organization for Economic Co-operation and Development, Paris, France.
48. Rodgman A., Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke 2009, CRC Press, Boca Raton, FL.
49. Sato M., Shames D.S., Gazdar A.F., Minna J.D. A translational view of the molecular pathogenesis of lung cancer. J. Thorac. Oncol. 2007, 2:327-343.
50. Schleef R.R., Vanscheeuwijck P.M., Schlage W.K., Borzelleca J.F., Coggins C.R.E., Haussmann H.-J. Animal models for three major cigarette-smoke-induced diseases. Inhalation Toxicology 2006, 851-873. CRC Press, Boca Raton, FL. second ed. H. Salem, S.A. Katz (Eds.).
51. Shimkin M.B., Stoner G.D. Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res. 1975, 21:1-58.
52. Stearman R.S., Dwyer-Nield L., Zerbe L., Blaine S.A., Chan Z., Bunn P.A., Johnson G.L., Hirsch F.R., Merrick D.T., Franklin W.A., Baron A.E., Keith R.L., Nemenoff R.A., Malkinson A.M., Geraci M.W. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol. 2005, 167:1763-1775.
53. Stinn W., Teredesai A., Anskeit E., Rustemeier K., Schepers G., Schnell P., Haussmann H.-J., Carchman R.A., Coggins C.R.E., Reininghaus W. Chronic nose-only inhalation study in rats, comparing room-aged sidestream cigarette smoke and diesel engine exhaust. Inhal. Toxicol. 2005, 17:549-576.
54. Stinn W., Teredesai A., Kuhl P., Knorr-Wittmann C., Kindt R., Coggins C., Haussmann H.-J. Mechanisms involved in A/J mouse lung tumorigenesis induced by inhalation of an environmental tobacco smoke surrogate. Inhal. Toxicol. 2005, 17:263-276.
55. Thompson A.B., Daughton D., Robbins R.A., Ghafouri M.A., Oehlerking M., Rennard S.I. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 1989, 140:1527-1537.
56. To M.D., Perez-Losada J., Mao J.H., Hsu J., Jacks T., Balmain A. A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat. Genet. 2006, 38:926-930.
57. US Department of Health and Human Services The Health Consequences of Smoking: A Report of the Surgeon General 2004, Office on Smoking and Health, Washington, DC.
58. US Institute of Medicine Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction 2001, National Academy Press, Washington, DC.
59. Vanscheeuwijck P.M., Teredesai A., Terpstra P.M., Verbeeck J., Kuhl P., Gerstenberg B., Gebel S., Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol. 2002, 40:113-131.
60. Walser T., Cui X., Yanagawa J., Lee J.M., Heinrich E., Lee G., Sharma S., Dubinett S.M. Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 2008, 5:811-815.
61. Wang M., Lemon W.J., Liu G., Wang Y., Iraqi F.A., Malkinson A.M., You M. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res. 2003, 63:3317-3324.
62. Witschi H. Carcinogenic activity of cigarette smoke gas phase and its modulation by beta-carotene and N-acetylcysteine. Toxicol. Sci. 2005, 84:81-87.
63. Witschi H. The complexities of an apparently simple lung tumor model: the A/J mouse. Exp. Toxicol. Pathol. 2005, 57(Suppl. 1):171-181.
64. Witschi H., Espiritu I., Dance S.T., Miller M.S. A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol. Sci. 2002, 68:322-330.
65. Witschi H., Espiritu I., Maronpot R.R., Pinkerton K.E., Jones A.D. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 1997, 18:2035-2042.
66. Witschi H., Espiritu I., Peake J.L., Wu K., Maronpot R.R., Pinkerton K.E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997, 18:575-586.
67. Witschi H.P. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology 1981, 21:95-104.
68. World Health Organization The Millennium Development Goals and Tobacco Control 2004, World Health Organization, Geneva, Switzerland.
69. Zeller W.J., Schmähl D. Relevance of gas and particulate phases of tobacco smoke for lung cancer formation: an experimental study in Syrian Golden hamsters. Cancer Detect. Prev. 1986, 9:91-97.